Rosemary compound shows potential in Alzheimer’s treatment

A new study suggests that rosemary might hold promise in treating Alzheimer’s disease. Researchers have focused on a substance called Carnosic acid, which is found in both rosemary and sage. This compound is known for its antioxidant and anti-inflammatory properties. In its natural form, Carnosic acid is unstable. However, scientists have created a stable version of it. Tests in mouse models of Alzheimer’s showed that this stable derivative improved memory. Neuroscientist Stuart Lipton noted that the drug not only slowed memory decline but also brought improvements close to normal levels. Lipton and his team believe this treatment could also be effective for other inflammatory conditions, such as type 2 diabetes and Parkinson’s disease. They found that Carnosic acid's anti-inflammatory properties could be beneficial. The researchers are optimistic about the potential for developing new medications quickly. Lipton mentioned that this new form of Carnosic acid might enhance the effectiveness of existing Alzheimer’s treatments while reducing side effects. The results of their study were published recently in the journal Antioxidants.